tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

ENTA Stock Latest News

Enanta price target raised to $24 from $23 at Citizens JMP
The FlyEnanta price target raised to $24 from $23 at Citizens JMP
26d ago
ENTA
Enanta price target raised to $23 from $21 at Citizens JMP
PremiumThe Fly
Enanta price target raised to $23 from $21 at Citizens JMP
2M ago
ENTA
Enanta Pharmaceuticals Reports Q2 2025 Financial Results
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Q2 2025 Financial Results
2M ago
ENTA
Enanta reports Q2 EPS ($1.06), consensus ($1.14)
PremiumThe Fly
Enanta reports Q2 EPS ($1.06), consensus ($1.14)
2M ago
ENTA
Is ENTA a Buy, Before Earnings?
PremiumPre-Earnings
Is ENTA a Buy, Before Earnings?
2M ago
ENTA
Enanta Pharmaceuticals Stockholders Approve Key Proposals in 2025
PremiumCompany AnnouncementsEnanta Pharmaceuticals Stockholders Approve Key Proposals in 2025
3M ago
8K
ENTA
Enanta Pharmaceuticals: Hold Rating Amid Delayed Launches and Strategic Advancements
Premium
Ratings
Enanta Pharmaceuticals: Hold Rating Amid Delayed Launches and Strategic Advancements
4M ago
ENTA
Enanta Pharmaceuticals Advances in Virology and Immunology
Premium
Company Announcements
Enanta Pharmaceuticals Advances in Virology and Immunology
5M ago
ENTA
Enanta CEO buys $256K in common stock
PremiumThe Fly
Enanta CEO buys $256K in common stock
5M ago
ENTA
Enanta Pharmaceuticals: Buy Rating Driven by Promising RSV Developments and Strategic Plans
PremiumRatings
Enanta Pharmaceuticals: Buy Rating Driven by Promising RSV Developments and Strategic Plans
5M ago
ENTA
Enanta reports Q1 EPS ($1.05), consensus ($1.35)
PremiumThe Fly
Enanta reports Q1 EPS ($1.05), consensus ($1.35)
5M ago
ENTA
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
PremiumPre-Earnings
Enanta Pharmaceuticals (ENTA) Q1 Earnings Cheat Sheet
5M ago
ENTA
Enanta to appeal ruling related to ‘953 patent infringement lawsuit
PremiumThe FlyEnanta to appeal ruling related to ‘953 patent infringement lawsuit
6M ago
PFE
ENTA
Enanta price target lowered to $18 from $27 at H.C. Wainwright
Premium
The Fly
Enanta price target lowered to $18 from $27 at H.C. Wainwright
6M ago
ENTA
Enanta price target lowered to $20 from $30 at Evercore ISI
Premium
The Fly
Enanta price target lowered to $20 from $30 at Evercore ISI
7M ago
ENTA
Enanta Pharmaceuticals Reports Promising Results for Pediatric RSV Drug
PremiumCompany Announcements
Enanta Pharmaceuticals Reports Promising Results for Pediatric RSV Drug
7M ago
8K
ENTA
Enanta announces ‘positive’ results from Phase 2 study of zelicapavir
PremiumThe Fly
Enanta announces ‘positive’ results from Phase 2 study of zelicapavir
7M ago
ENTA
Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility
PremiumCompany Announcements
Enanta Pharmaceuticals’ Reduced Reporting: Potential Impact on Investor Appeal and Stock Volatility
7M ago
ENTA
Enanta price target lowered to $14 from $16 at Oppenheimer
PremiumThe Fly
Enanta price target lowered to $14 from $16 at Oppenheimer
7M ago
ENTA
Enanta price target lowered to $20 from $26 at Baird
PremiumThe FlyEnanta price target lowered to $20 from $26 at Baird
7M ago
ENTA
Enanta price target lowered to $21 from $22 at JMP Securities
Premium
The Fly
Enanta price target lowered to $21 from $22 at JMP Securities
7M ago
ENTA
Enanta Pharmaceuticals Reports Q4 2024 Financials
Premium
Company Announcements
Enanta Pharmaceuticals Reports Q4 2024 Financials
7M ago
ENTA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >